Ac immune aci-35.030 phase 1b/2a trial interim data confirm consistent safety and potent immunogenicity of ptau alzheimer's vaccine in high-dose cohort

Observed strong induction of antibodies specific for pathological forms of tau with aci-35.030 treatment
ACIU Ratings Summary
ACIU Quant Ranking